Fig. 1: The definition of the clinical development programs (CDPs) based on drugs and their corresponding diseases.
From: Dynamic clinical trial success rates for drugs in the 21st century

The CDP of a drug for the treatment of a disease was created by merging all trials of this drug treating same disease, and the trials of this drug treating other diseases were used to generate new CDPs. Taking “vilaprisan” as an example, it was clinically assessed for two diseases (endometriosis and uterine leiomyoma), which led to two distinct CDPs for this drug.